These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6819093)

  • 1. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 3. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug sensitivity of tubercle bacilli to ethambutol and rifampicin determined by the Canetti proportional method].
    Woźniak-Dubla S; Tomaszkiewicz L
    Pneumonol Pol; 1977 Dec; 45(12):785-91. PubMed ID: 414214
    [No Abstract]   [Full Text] [Related]  

  • 6. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
    Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1973; 51(2):56-61. PubMed ID: 4203996
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies for the determination of clinically available criteria of resistance of tubercle bacilli to rifampicin.
    Gomi J; Yanagisawa K; Murohashi T
    Kekkaku; 1970 Oct; 45(10):317-22. PubMed ID: 4991063
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of the criteria of chemoresistance to rifampicin and ethambutol].
    Bogdănescu V; Negulescu E; Ticău S; Vlădescu D
    Ftiziologia; 1973; 22(6):611-21. PubMed ID: 4204427
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriological criteria of rifampicin and ethambutol resistance].
    Afanasieva JP
    G Ital Chemioter; 1972; 19(2):16-9. PubMed ID: 4199028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)].
    Xiao XL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Aug; 4(4):224-5. PubMed ID: 6804194
    [No Abstract]   [Full Text] [Related]  

  • 16. [A study of the composition of rifampicin- and ethambutol-resistant variants of wild strains of M. tuberculosis, cultivated on Loewenstein-Jensen medium].
    Le Lirzin M; Djurovic V
    Ann Inst Pasteur (Paris); 1971 Apr; 120(4):531-48. PubMed ID: 4998275
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].
    Kameda K; Okamura S; Yamamoto S; Iwai K
    Kekkaku; 1975 Jul; 50(7):185-9. PubMed ID: 810614
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
    Zhao JR; Bai YJ; Wang Y; Zhang QH; Luo M; Yan XJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):328-32. PubMed ID: 15786899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.